Carl Zeiss Meditec AG reaffirmed earnings guidance for the year 2021/22. For the year 2021/22, the company's revenue is expected to grow at least to the same extent as the market.
Market Closed -
Other stock markets
|
After market 15:59:25 | |||
87.55 EUR | -2.07% | 87.85 | +0.34% |
05-23 | Carl Zeiss Meditec very weak - support still holding | DP |
05-23 | Goldman downgrades Carl Zeiss Meditec to 'Sell' - Target 90 euros | DP |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.42% | 8.7B | |
+7.02% | 219B | |
+10.72% | 192B | |
+17.84% | 142B | |
+29.55% | 111B | |
+2.09% | 65.32B | |
+14.10% | 52.45B | |
+3.01% | 49.8B | |
+4.49% | 43.43B | |
+1.11% | 35.95B |
- Stock Market
- Equities
- AFX Stock
- News Carl Zeiss Meditec AG
- Carl Zeiss Meditec AG Reaffirms Earnings Guidance for the Year 2021/22